The Renfrew Center of Radnor
Welcome,         Profile    Billing    Logout  
 6 Trials 
5 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lowe, Michael
Neo-DREAM, NCT03567889 / 2021-003064-27: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

Recruiting
3
186
Europe, US
Daromun, Surgery, Adjuvant therapy
Philogen S.p.A., Philogen S.p.A.
Melanoma Stage IIIB/C
06/24
06/26
NCT04427306: Neoadjuvant T-VEC in High Risk Early Melanoma

Suspended
2
6
US
T-Vec, talimogene laherparepvec, Amgen
University of California, Davis, Amgen
Melanoma
06/22
05/24
NCT02964559: Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer

Completed
2
11
US
Pembrolizumab, Keytruda, Lambrolizumab, MK-3475, SCH 900475
Emory University, Merck Sharp & Dohme LLC, National Institutes of Health (NIH), National Cancer Institute (NCI)
Recurrent Skin Carcinoma, Skin Squamous Cell Carcinoma
05/21
05/21
NCT03769155: VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma

Active, not recruiting
1
41
US
Ipilimumab, BMS-734016, MDX-010, MDX-CTLA4, Yervoy, Nivolumab, BMS-936558, MDX-1106, NIVO, ONO-4538, Opdivo, VX15/2503, moAb VX15/2503, Pepinemab, Surgery
Emory University, Bristol-Myers Squibb, Vaccinex Inc., National Institutes of Health (NIH), National Cancer Institute (NCI)
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8
12/23
12/32
MERLIN_001, NCT04759781: MElanoma Research Lymph Node Prediction Implementation National_001

Active, not recruiting
N/A
1820
US
SkylineDx
Melanoma
06/24
06/29

Download Options